Warning! GuruFocus detected
4 Severe warning signs
with CEL.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Celadon Pharmaceuticals PLC
ISIN : GB00BDQYGP38
Compare
Compare
Traded in other countries / regions
CEL.UK IPO Date
2022-03-29Description
Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis. It operates only in the UK and has only one geographical area.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | 0.29 | |||||
| Debt-to-Equity | 1.97 | |||||
| Debt-to-EBITDA | -1.1 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | -6.39 | |||||
| Beneish M-Score | -3.22 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -125.4 | |||||
| 3-Year EPS without NRI Growth Rate | -82.3 | |||||
| 3-Year FCF Growth Rate | -98.7 | |||||
| 3-Year Book Growth Rate | 190.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.79 | |||||
| 9-Day RSI | 37.97 | |||||
| 14-Day RSI | 35.75 | |||||
| 3-1 Month Momentum % | 26.67 | |||||
| 6-1 Month Momentum % | -32.14 | |||||
| 12-1 Month Momentum % | -75.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.92 | |||||
| Quick Ratio | 1.41 | |||||
| Cash Ratio | 0.02 | |||||
| Days Sales Outstanding | 1033.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.4 | |||||
| Shareholder Yield % | -30.75 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 346.92 | |||||
| Operating Margin % | -3793.85 | |||||
| Net Margin % | -4024.62 | |||||
| FCF Margin % | -4418.46 | |||||
| ROE % | -182.53 | |||||
| ROA % | -57.83 | |||||
| ROIC % | -63.51 | |||||
| 3-Year ROIIC % | -121.92 | |||||
| ROC (Joel Greenblatt) % | -74.45 | |||||
| ROCE % | -61.3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 37.5 | |||||
| PB Ratio | 2.03 | |||||
| Price-to-Tangible-Book | 2.5 | |||||
| EV-to-EBIT | -2.03 | |||||
| EV-to-EBITDA | -2.29 | |||||
| EV-to-Revenue | 76.53 | |||||
| EV-to-FCF | -1.79 | |||||
| Earnings Yield (Greenblatt) % | -49.04 | |||||
| FCF Yield % | -111.25 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Celadon Pharmaceuticals PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 0.13 | ||
| EPS (TTM) (£) | -0.082 | ||
| Beta | -2.6 | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 100.46 | ||
| 14-Day RSI | 35.75 | ||
| 14-Day ATR (£) | 0.039762 | ||
| 20-Day SMA (£) | 0.12231 | ||
| 12-1 Month Momentum % | -75.95 | ||
| 52-Week Range (£) | 0.02211 - 1.225 | ||
| Shares Outstanding (Mil) | 68.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Celadon Pharmaceuticals PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Celadon Pharmaceuticals PLC Stock Events
| Event | Date | Price (£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Celadon Pharmaceuticals PLC Frequently Asked Questions
What is Celadon Pharmaceuticals PLC(LSE:CEL)'s stock price today?
The current price of LSE:CEL is £0.08. The 52 week high of LSE:CEL is £1.23 and 52 week low is £0.02.
When is next earnings date of Celadon Pharmaceuticals PLC(LSE:CEL)?
The next earnings date of Celadon Pharmaceuticals PLC(LSE:CEL) is 2025-05-14 Est..
Does Celadon Pharmaceuticals PLC(LSE:CEL) pay dividends? If so, how much?
Celadon Pharmaceuticals PLC(LSE:CEL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers